Christopher Mutz, HEAD OF RARE DISEASE at ANI PHARMACEUTICALS INC (ANIP), sold 2,000 shares at $61.61 ($123K) on 2024-05-21, disclosed to the SEC on 2024-05-22.
Open-market sale of $123k ANIP by HEAD OF RARE DISEASE. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ANIP | SELL | 2026-03-04 | $31K | — | Filing → |
| ANIP | SELL | 2026-02-23 | $415K | — | Filing → |
| ANIP | SELL | 2026-02-17 | $538K | — | Filing → |